These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2608299)

  • 21. [Corpus cavernosum injection treatment of erectile impotence].
    Lenk S; Schönherr G; Korner I
    Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
    Stief CG; Bähren W; Beckert R; Altwein JE
    J Urol (Paris); 1986; 92(6):349-51. PubMed ID: 3794379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intracavernous pharmacotherapy.
    Sidi AA
    Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biweekly intracavernous administration of papaverine for erectile dysfunction.
    Mooradian AD; Morley JE; Kaiser FE; Davis SS; Viosca SP; Korenman SC
    West J Med; 1989 Nov; 151(5):515-7. PubMed ID: 2603417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A program of intracavernous drug-induced erection for the treatment of impotence].
    Navío S; Allona A; Serrano A; Vallejo J; del Hoyo J; Rivas JA; Escudero A
    Actas Urol Esp; 1993 Jan; 17(1):62-7. PubMed ID: 8452086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
    Tang SF; Chu NK; Wong MK
    Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Erectile dysfunction of male spinal cord injury patients].
    Schurch B; Kuhn W
    Schweiz Rundsch Med Prax; 1990 Sep; 79(38):1085-8. PubMed ID: 2218240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
    Chochina L; Naudet F; Chéhensse C; Manunta A; Damphousse M; Bonan I; Giuliano F
    Sex Med Rev; 2016 Jul; 4(3):257-269. PubMed ID: 27871959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intracavernous injection of vasoactive substances in the treatment of erectile dysfunction].
    Wehnert J; Kramer J; Weller J; Leike S
    Z Urol Nephrol; 1988 Feb; 81(2):73-8. PubMed ID: 3369250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of impotence due to spinal cord injury using low dose papaverine.
    Yarkony GM; Chen D; Palmer J; Roth EJ; Rayner S; Lovell L
    Paraplegia; 1995 Feb; 33(2):77-9. PubMed ID: 7753572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Induction of an erection using papaverine].
    Terek A; Sekei J; Getz F
    Urol Nefrol (Mosk); 1989; (3):69-71. PubMed ID: 2773185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intracavernous self-injection for treatment of erectile dysfunction inpatients with spinal cord injuries].
    Sønksen JO; Hansen EF; Biering-Sørensen F; Colstrup H
    Ugeskr Laeger; 1990 Oct; 152(41):3006-9. PubMed ID: 2238171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostaglandin treatment in neurological patients with erectile dysfunction].
    Conejero Sugrañes J; Muñoz Villellas A; Sarrias Lorenz F; Ramírez Garceran L
    Arch Esp Urol; 2002; 55(1):63-8. PubMed ID: 11957754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcutaneous nitroglycerin in the treatment of erectile dysfunction in spinal cord injured.
    Sønksen J; Biering-Sørensen F
    Paraplegia; 1992 Aug; 30(8):554-7. PubMed ID: 1522996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction].
    Steffens J; Postma HJ; Steffens L
    Urologe A; 1988 Jan; 27(1):14-6. PubMed ID: 3363768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
    Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
    Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury.
    Earle CM; Keogh EJ; Ker JK; Cherry DJ; Tulloch AG; Lord DJ
    Paraplegia; 1992 Apr; 30(4):273-6. PubMed ID: 1625897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H; Goldstein I; Krane RJ
    Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation and treatment of erectile dysfunction following spinal cord injury: a review.
    Linsenmeyer TA
    J Am Paraplegia Soc; 1991 Apr; 14(2):43-51. PubMed ID: 2051156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.